JUPITER, FL - February 29, 2016 - Scientists from the Florida campus of The Scripps Research Institute (TSRI) have for the first time developed a way to predict how a specific type of stem cell will act against different diseases. With more than 500 stem cell-based therapies currently in clinical trials, the findings could have an impact on evaluating these therapies and developing new ones.
The new study, published recently by the journal EBioMedicine, was led by Professor Donald G. Phinney, acting chair of Scripps Florida's Department of Molecular Therapeutics.